Dr. Li Tao's Joint Laboratory of Regenerative Medicine will settle in Xi'an High tech Zone


On the afternoon of November 23rd, a press conference was held in Xi'an between Xi'an Haibei Health Management Co., Ltd. and the China US Cyber Regenerative Medicine Postdoctoral Workstation and Key Laboratory.

 

At the meeting, it was announced that Li Tao, a postdoctoral fellow at the University of Tokyo and director of the Shenzhen Stem Cell Engineering Research and Development Center, along with his research team, will establish a joint laboratory and postdoctoral research workstation for regenerative medicine at the Haibei Clinic in Xi'an High tech Zone on December 15th. This will help Xi'an build a gathering place for high-level innovative talents in regenerative medicine, stimulate talent innovation vitality, and create a new situation for the regenerative medicine industry in Shaanxi.

The soon to be completed Haibei and Sino-U.S. Saier Postdoctoral Workstation and Key Laboratory of Regenerative Medicine will be dedicated to the basic and translational research of regenerative medicine technology. The laboratory will collaborate with well-known domestic and foreign universities and authoritative experts to jointly build a high-end biomedical research innovation and transformation platform, carry out scientific research and clinical application research on stem cells for the repair of nerves, lungs, hearts, liver, kidneys, and nervous systems, and focus on building an integrated regenerative medicine complex that integrates production, research, education, and medicine, filling the research gap in the field of regenerative medicine in Shaanxi.

Xu Kai, representative of Sino US Saier Biotechnology Co., Ltd., stated that the construction of this research workstation is centered around Haibei Medical, relying on Professor Li Tao's rich clinical research experience and industry influence to attract high-level talents in biomedical fields such as master's and doctoral degrees, provide them with research platforms and technological guidance, and accumulate high-level talent for the development of regenerative medicine, scientific research, and industry in the high-tech zone, Xi'an city, and even in Shaanxi and Northwest China. It plays a strategic guidance and promotion role, promoting the development of western regenerative medicine and benefiting the people of Shaanxi.

Wang Jianfeng, Deputy General Manager of Xi'an Haibei Health Management Co., Ltd., stated that the soon to be completed postdoctoral workstation and key laboratory in regenerative medicine aims to play the role of a laboratory "think tank". Through an authoritative Expert Team, advanced technological innovation, and a sound quality control system, scientific research achievements in clinical treatment, sub health intervention, health care and anti-aging will be introduced to Xi'an, providing protection for the health of the people in Xi'an and even the whole province, and creating a Shaanxi sample to support the construction of Healthy China 2030.

As the first general health diagnosis and treatment entrusted center in China, Haibei Clinic utilizes advanced global medical concepts and technologies to achieve full lifecycle health management of "risk control, disease intervention, health care and anti-aging". Through multiple disciplines such as clinical medicine, precision medicine, functional medicine, and preventive medicine, Haibei Clinic adopts an integrated service approach of "examination, treatment, and management", focusing on the perfect combination of "light medical care+lifestyle+natural therapy". Through independent intervention management and the combination of global health and medical resources, it provides people with better quality of life and a longer life cycle.

It is reported that Sino-U.S. Cell is a biotech enterprise specializing in stem cell basic research, clinical application research, and stem cell technology support services. It has a professional technology research and development team led by multiple experts and domestic and foreign scholars with outstanding achievements in the field of stem cells. Li Tao, Chairman of Sino US Cell Biotechnology, has established and improved the technical quality control system for the first iPS project in China. He has taken the lead in developing the culture medium formula and culture method for cord blood stem cells, and has isolated nearly ten different sources of stem cells, establishing the first stem cell bank technology system in China.

 

The best medical technique is to awaken the body's self-healing ability and heal without treatment. In order to implement the national "Healthy China 2030" strategy and effectively transform from "treatment centered" to "prevention centered", Haibei Medical has jointly established a joint laboratory and postdoctoral research workstation for regenerative medicine with China US Sail. We have introduced a research team led by Dr. Li Tao, a world-renowned regenerative medicine scientist, to jointly usher in a new era of health entrusted management in the northwest region, create a new model of health management, and serve as a demonstration and guide for the health of people throughout the entire life cycle of "prevention centered" nationwide.

- END -